Today's Top 20 Healthcare News Articles
-
HCA names CFO of Gulf Coast division
Houston-based HCA Healthcare Gulf Coast Division has named Gary Searls CFO. -
Orlando Health to close Florida hospital, open new facility
Orlando (Fla.) Health will close its Longwood, Fla.-based South Seminole Hospital and move patients and employees to its new Orlando Health Lake Mary (Fla.) Hospital on Jan. 11. -
Cleveland Clinic exec heads to Joint Commission
The Joint Commission has appointed Marleina Davis as executive vice president and chief legal officer.
-
New York hospital names CNO
The University of Rochester (N.Y.) Medical Center has named Katherine Valcin, DNP, RN, as chief nursing executive for the system and CNO of Strong Memorial Hospital. -
Intermountain names new chief quality officer
Salt Lake City-based Intermountain Health has appointed Cara Camiolo, MD, as the system's new chief quality and safety officer. -
Why wellness is a high priority for Banner Health's CEO
Amy Perry's first 100 days as Banner Health CEO involved a great deal of listening to employees, with a focus on the organization's vision. -
2025's most anticipated 2025 drug approvals: GoodRx
GoodRx is monitoring seven potential FDA drug approvals in 2025, including a possible expanded label for Ozempic.
-
SUNY Upstate asks New York Governor for $450M to build new ED
The State University of New York's board of trustees in Albany have asked Gov. Kathy Hochul for $450 million to develop a hospital annex for Syracuse, N.Y.-based Upstate University Hospital to house a new emergency department, burn center and additional operating rooms, Syracuse.com reported Jan. 8. -
Houston Methodist hospital names president of medical staff
Christi Pramudji Dawe, MD, has been named president of the medical staff at Houston Methodist West Hospital. -
Hartford HealthCare uses AI to identify critical conditions faster
Hartford (Conn.) HealthCare has partnered with Aidoc to implement artificial intelligence technology aimed at accelerating diagnoses and improving patient care. -
A busy hospital M&A period continues
The beginning of the new year is off to a busy start for hospital and health system mergers and acquisitions with several deals announced, advancing or finalized.
-
What 12 health system marketing chiefs are watching in '25
Artificial intelligence and personalizing the patient experience via digital are top of mind for health system marketing chiefs in 2025. -
Medical schools see record-high enrollment as applications fall: 10 takeaways
While the total number of applications declined in the 2024-to-2025 academic year, enrollment in U.S. medical schools reached a new high, according to data released Jan. 9 by the Association of American Medical Colleges. -
Aspirus Michigan hospital ends labor, delivery services
Laurium, Mich.-based Aspirus Keweenaw Hospital, part of Wausau, Wis.-based Aspirus Health, ended its labor and delivery services on Dec. 31. -
Labcorp to manage NJ system's lab operations
Labcorp has struck an agreement to manage the daily operations of Vineland, N.J.-based Inspira Health's hospital laboratories in Vineland, Elmer, and Mullica Hill. -
New York hospital to resume open-heart surgeries after 8-month pause
Wynn Hospital in Utica, N.Y., plans to resume open-heart surgery sometime in January after an eight-month pause. -
Some pharmaceutical mergers lower drug prices: Study
Pharmaceutical companies merging are thought to increase drug prices, but research from Iowa City-based University of Iowa seems to dispel this theory when the mergers are between generic drugmakers. -
NYU Langone spotlights quality in new ad push
New York City-based NYU Langone Health has launched a new ad campaign focused on quality and safety to stand out in the city's crowded healthcare market. -
Virginia hospital indicted for fraud tied to unnecessary surgeries
Chesapeake (Va.) Regional Medical Center is facing federal criminal charges related to unnecessary surgeries performed by a physician who was convicted of 52 federal counts in 2020. -
FDA mandates warnings for 2 RSV vaccines
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of Guillan-Barré syndrome.
Page 1 of 50